Vimarsana
Biggest News Aggregation in the World

Page 15 - Report From News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Report From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Report From Today - Breaking & Trending Today

A GI Doc's Help Can Be Crucial for Pregnant Women With IBD - Vimarsana News

A GI Doc's Help Can Be Crucial for Pregnant Women With IBD

Women with inflammatory bowel disease (IBD) face several concerns related to their reproductive health decisions, from contraception to pregnancy to delivery.

Frontiers | Analysis of Content, Social Networks, and Sentiment of Front-of-Pack Nutrition Labeling in the European Union on Twitter - Vimarsana News

Frontiers | Analysis of Content, Social Networks, and Sentiment of Front-of-Pack Nutrition Labeling in the European Union on Twitter

In recent years, a concerted political effort has been made at national and EU level to promote the consumption of healthy foods. The European Commission (EC) expressed a need for a harmonized, mandatory front-of-pack nutrition labelling (FOPL) system at EU level. The EC intends to adopt the proposal by the end of 2022. Our research work seeks to understand the public discourse on FOPL in the EU through Twitter, by content analysis of tweets, sentiment analysis and mapping network characteristics. Search and data collection of tweets were carried out by using Twitter Application programming in...

Ukraine SITREP for April 13th - Vimarsana News

Ukraine SITREP for April 13th

Ukraine is claiming they hit the Russian flagship of the Black Sea Fleet with two cruise missiles, US furnished Mi-17 helicopters going and then not going to Ukraine, A report from an American serving in Ukraine and Russian losses in perspective.

Source: sofrep.com
Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention - Vimarsana News

Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association , found VASCEPA® significantly reduced the risk of cardiovascular death,... | March 10, 2022

Amarin Corporation plc: Latest analysis shows VASCEPA (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention - Vimarsana News

Amarin Corporation plc: Latest analysis shows VASCEPA (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA significantly reduced the risk of cardiovascular death, strokes